NOCIL194.49

NOCIL Limited

· Chemicals
₹ CrorePeersHSCLROSSARINAVINFLUORDDEVPLSTIKTATACHEMCHEMPLASTSAARTIINDJGCHEMMcap ₹3,248 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
NOCIL
FY26
HSCL
FY26
ROSSARI
FY26
NAVINFLUOR
FY26
Peer
Median
Valuation — at last close
P/E58.41×44.05×16.77×66.72×44.05× +33%
P/B1.83×7.04×1.88×11.24×7.04× -74%
EV/EBITDA28.87×35.32×9.80×41.29×35.32× -18%
Market Cap₹3,248 Cr₹33,509 Cr₹2,503 Cr₹44,680 Cr₹33,509 Cr -90%
Growth
Revenue CAGR 3Y-6.94%3.76%13.11%16.84%13.11% -153%
Revenue CAGR 5Y7.10%22.65%27.57%22.95%22.95% -69%
Net Income CAGR 3Y-28.02%51.80%11.63%20.93%20.93% -234%
Revenue YoY (latest Q)19.87%28.04%28.23%44.07%28.23% -30%
Net Income YoY (latest Q)60.83%27.36%4.46%107.67%27.36% +122%
Profitability
EBITDA Margin7.73%20.64%11.93%32.64%20.64% -63%
Net Income Margin4.27%16.20%6.23%20.02%16.20% -74%
Return on Common Equity3.14%15.78%11.19%16.69%15.78% -80%
Return on Capital Employed2.41%17.63%13.79%17.56%17.56% -86%
Return on Assets2.64%11.97%6.52%10.40%10.40% -75%
Credit & Quality
Total Debt/Equity0.00×0.16×0.31×0.31×0.31× -100%
Interest Coverage33.04×13.89×7.24×7.91×7.91× +318%
Scale — latest FY
Revenue / Total Income₹1,303 Cr₹4,661 Cr₹2,396 Cr₹3,314 Cr₹3,314 Cr -61%
Net Income₹55.6 Cr₹755 Cr₹149 Cr₹664 Cr₹664 Cr -92%
Total Assets₹2,111 Cr₹6,306 Cr₹2,289 Cr₹6,379 Cr₹6,306 Cr -67%
EPS₹3.33₹15.08₹26.95₹130.67₹26.95 -88%
Book Value per Share₹106.18₹94.39₹240.74₹775.53₹240.74 -56%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.